Susceptibility of clinical isolates of frequently encountered bacterial species to tigecycline one year after the introduction of this new class of antibiotics: results of the second multicentre surveillance trial in Germany (G-TEST II, 2007)

Tigecycline, a broad-spectrum antibiotic for parenteral use, was introduced in Germany in May 2006. In the G-TEST-II trial, the susceptibility of isolates, recovered in 2007 from hospitalised patients in 15 centres, was assessed against tigecycline and comparators. Susceptibility tests were performe...

Descripción completa

Detalles Bibliográficos
Autores principales: Kresken, M., Leitner, E., Seifert, H., Peters, G., von Eiff, C.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723668/
https://www.ncbi.nlm.nih.gov/pubmed/19296137
http://dx.doi.org/10.1007/s10096-009-0725-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2723668/
https://www.ncbi.nlm.nih.gov/pubmed/19296137
http://dx.doi.org/10.1007/s10096-009-0725-5

Ejemplares similares